retatrutide type 2 diabetes trial nct ESC 2024: improves lipid and cardiovascular risk profile in Phase II Looking forward to when #retatrutide's

If blood sugars are still high, the Rybelsus dose may be increased to 14mg once daily after at least 30 days on the 7mg dose

Successful application of various GLP-1 mimetics to treat type 2 diabetes mellitus (T2DM) and obesity highlights the clinical value of this group of drug targets 3

Functional medicine has opened minds to the concept of root cause medicine, but as we traverse through the bodys systems

Albakr, R

Some healthcare providers may have less experience with these treatments, while others focus on them more regularly

However, the results may vary based on individual factors such as adherence to the program, starting weight, and overall lifestyle changes